Linked Life Data

19672151

Source:http://linkedlifedata.com/resource/pubmed/id/19672151

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-8-12
pubmed:abstractText
The pathway that emerging medical technologies take to incorporation into routine medical care in the United States is a product of the social, economic, and political milieu. Our review explores how this milieu brought the incorporation of proton beam therapy into the healthcare delivery system to its current point. We look at how new technologies are presently accepted into this system and discuss the emerging trends--such as the use of evidence-based assessment of technology, coverage with evidence policies, and comparative effectiveness analysis--that are affecting proton beam therapy's effort to finds its place in the pantheon of available medical treatments for patients with cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1528-9117
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
333-8
pubmed:meshHeading
pubmed:articleTitle
Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States.
pubmed:affiliation
Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6951, USA. msteinberg@mednet.ucla.edu
pubmed:publicationType
Journal Article, Review